Previous Article | Next Article 
Clinical and Diagnostic Laboratory Immunology, November 1999, p. 934-937, Vol. 6, No. 6
1071-412X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Tuberculin-Purified Protein Derivative-, MPT-64-, and
ESAT-6-Stimulated Gamma Interferon Responses in Medical Students
before and after Mycobacterium bovis BCG Vaccination and
in Patients with Tuberculosis
P. D. R.
Johnson,1,*
R. L.
Stuart,1
M. L.
Grayson,1
D.
Olden,1
A.
Clancy,2
P.
Ravn,3
P.
Andersen,3
W. J.
Britton,4 and
J.
S.
Rothel2
Department of Infectious Diseases and
Clinical Epidemiology, Monash Medical Centre, Clayton,
Victoria,1 Biosciences Division, CSL
Limited, Melbourne, Victoria,2 and
Centenary Institute of Cancer Medicine and Cell Biology,
Newtown, New South Wales,4 Australia, and
Statens Serum Institute, Copenhagen,
Denmark3
Received 18 May 1999/Returned for modification 21 July
1999/Accepted 10 August 1999
QuantiFERON-TB (QIFN) (CSL Limited) is a
whole-blood assay for the recognition of infection with
Mycobacterium tuberculosis. QIFN measures gamma interferon
(IFN-
) production when purified protein derivatives (PPDs) of
mycobacteria are incubated with venous blood samples. The specificity
of QIFN in medical students before and after BCG immunization was
assessed, and sensitivity in patients with tuberculosis was assessed.
Antigens were PPD derived from M. tuberculosis and two
M. tuberculosis-specific proteins, ESAT-6 and MPT-64. Of 60 medical students, all of whom had 0-mm tuberculin skin tests (TSTs) at
study entry, 58 (97%) were initially classified as negative for
M. tuberculosis infection by PPD QIFN. Five months after
BCG immunization, 7 of 54 students (13%) had a TST result of
10 mm
and 11 of 54 students (20%) tested positive by PPD QIFN. ESAT-6- and
MPT-64-stimulated IFN-
responses in the medical students were
negative prior to and after BCG immunization. For patients with active
tuberculosis, 12 of 19 (63%) were positive by PPD QIFN, 11 of 19 (58%) were positive by ESAT-6 QIFN, and 0 of 12 were positive by
MPT-64 QIFN. In conclusion, PPD QIFN was negative in 97% of a low-risk
population who had not received BCG and who had negative TSTs. The
specificities of both the TST and PPD QIFN were reduced following BCG
immunization. PPD QIFN and ESAT-6 QIFN were of similar and moderate
sensitivity in patients with active tuberculosis, but ESAT-6 QIFN is
likely to be more specific because it is not influenced by past BCG exposure.
*
Corresponding author. Mailing address: Department of
Infectious Diseases and Clinical Epidemiology, Monash Medical Centre, Clayton 3168, Victoria, Australia. Phone: 613 9594 4563. Fax: 613 9594 4533. E-mail Paul.Johnson{at}med.monash.edu.au.
Clinical and Diagnostic Laboratory Immunology, November 1999, p. 934-937, Vol. 6, No. 6
1071-412X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
de Perio, M. A., Tsevat, J., Roselle, G. A., Kralovic, S. M., Eckman, M. H.
(2009). Cost-effectiveness of Interferon Gamma Release Assays vs Tuberculin Skin Tests in Health Care Workers. Arch Intern Med
169: 179-187
[Abstract]
[Full Text]
-
Pai, M., Zwerling, A., Menzies, D.
(2008). Systematic Review: T-Cell-based Assays for the Diagnosis of Latent Tuberculosis Infection: An Update. ANN INTERN MED
149: 177-184
[Abstract]
[Full Text]
-
Menzies, D., Pai, M., Comstock, G.
(2007). Meta-analysis: New Tests for the Diagnosis of Latent Tuberculosis Infection: Areas of Uncertainty and Recommendations for Research. ANN INTERN MED
146: 340-354
[Abstract]
[Full Text]
-
Araoz, R., Honore, N., Cho, S., Kim, J.-P., Cho, S.-N., Monot, M., Demangel, C., Brennan, P. J., Cole, S. T.
(2006). Antigen Discovery: a Postgenomic Approach to Leprosy Diagnosis. Infect. Immun.
74: 175-182
[Abstract]
[Full Text]
-
Whalen, C. C.
(2005). Diagnosis of Latent Tuberculosis Infection: Measure for Measure. JAMA
293: 2785-2787
[Full Text]
-
Ravn, P., Munk, M. E., Andersen, A. B., Lundgren, B., Lundgren, J. D., Nielsen, L. N., Kok-Jensen, A., Andersen, P., Weldingh, K.
(2005). Prospective Evaluation of a Whole-Blood Test Using Mycobacterium tuberculosis-Specific Antigens ESAT-6 and CFP-10 for Diagnosis of Active Tuberculosis. CVI
12: 491-496
[Abstract]
[Full Text]
-
Avgustin, B., Kotnik, V., Skoberne, M., Malovrh, T., Skralovnik-Stern, A., Tercelj, M.
(2005). CD69 Expression on CD4+ T Lymphocytes after In Vitro Stimulation with Tuberculin Is an Indicator of Immune Sensitization against Mycobacterium tuberculosis Antigens. CVI
12: 101-106
[Abstract]
[Full Text]
-
Taggart, E. W., Hill, H. R., Ruegner, R. G., Martins, T. B., Litwin, C. M.
(2004). Evaluation of an In Vitro Assay for Gamma Interferon Production in Response to Mycobacterium tuberculosis Infections. CVI
11: 1089-1093
[Abstract]
[Full Text]
-
Scarpellini, P., Tasca, S., Galli, L., Beretta, A., Lazzarin, A., Fortis, C.
(2004). Selected Pool of Peptides from ESAT-6 and CFP-10 Proteins for Detection of Mycobacterium tuberculosis Infection. J. Clin. Microbiol.
42: 3469-3474
[Abstract]
[Full Text]
-
Brock, I., Weldingh, K., Leyten, E. M. S., Arend, S. M., Ravn, P., Andersen, P.
(2004). Specific T-Cell Epitopes for Immunoassay-Based Diagnosis of Mycobacterium tuberculosis Infection. J. Clin. Microbiol.
42: 2379-2387
[Abstract]
[Full Text]
-
Scholvinck, E., Wilkinson, K. A., Whelan, A. O., Martineau, A. R., Levin, M., Wilkinson, R. J.
(2004). Gamma Interferon-Based Immunodiagnosis of Tuberculosis: Comparison between Whole-Blood and Enzyme-Linked Immunospot Methods. J. Clin. Microbiol.
42: 829-831
[Abstract]
[Full Text]
-
Black, G. F., Weir, R. E., Chaguluka, S. D., Warndorff, D., Crampin, A. C., Mwaungulu, L., Sichali, L., Floyd, S., Bliss, L., Jarman, E., Donovan, L., Andersen, P., Britton, W., Hewinson, G., Huygen, K., Paulsen, J., Singh, M., Prestidge, R., Fine, P. E. M., Dockrell, H. M.
(2003). Gamma Interferon Responses Induced by a Panel of Recombinant and Purified Mycobacterial Antigens in Healthy, Non-Mycobacterium bovis BCG-Vaccinated Malawian Young Adults. CVI
10: 602-611
[Abstract]
[Full Text]
-
Doherty, T. M., Demissie, A., Olobo, J., Wolday, D., Britton, S., Eguale, T., Ravn, P., Andersen, P.
(2002). Immune Responses to the Mycobacterium tuberculosis-Specific Antigen ESAT-6 Signal Subclinical Infection among Contacts of Tuberculosis Patients. J. Clin. Microbiol.
40: 704-706
[Abstract]
[Full Text]
-
Hersh, A., von Reyn, C. F., Herzmann, C., Mazurek, G. H.
(2002). Interferon Assay Compared to Tuberculin Skin Testing for Latent Tuberculosis Detection. JAMA
287: 450-452
[Full Text]
-
Arend, S. M., Engelhard, A. C. F., Groot, G., de Boer, K., Andersen, P., Ottenhoff, T. H. M., van Dissel, J. T.
(2001). Tuberculin Skin Testing Compared with T-Cell Responses to Mycobacterium tuberculosis-Specific and Nonspecific Antigens for Detection of Latent Infection in Persons with Recent Tuberculosis Contact. CVI
8: 1089-1096
[Abstract]
[Full Text]
-
Mazurek, G. H., LoBue, P. A., Daley, C. L., Bernardo, J., Lardizabal, A. A., Bishai, W. R., Iademarco, M. F., Rothel, J. S.
(2001). Comparison of a Whole-Blood Interferon {gamma} Assay With Tuberculin Skin Testing for Detecting Latent Mycobacterium tuberculosis Infection. JAMA
286: 1740-1747
[Abstract]
[Full Text]
-
Vordermeier, H. M., Whelan, A., Cockle, P. J., Farrant, L., Palmer, N., Hewinson, R. G.
(2001). Use of Synthetic Peptides Derived from the Antigens ESAT-6 and CFP-10 for Differential Diagnosis of Bovine Tuberculosis in Cattle. CVI
8: 571-578
[Abstract]
[Full Text]
-
Katial, R. K., Hershey, J., Purohit-Seth, T., Belisle, J. T., Brennan, P. J., Spencer, J. S., Engler, R. J. M.
(2001). Cell-Mediated Immune Response to Tuberculosis Antigens: Comparison of Skin Testing and Measurement of In Vitro Gamma Interferon Production in Whole-Blood Culture. CVI
8: 339-345
[Abstract]
[Full Text]